In UK Goodwin Procter, advised on the matter. Goodwin Procter advised Synaffix BV with a team including Andrew Harrow (Picture – Corporate M&A), Malcolm Bates (IP&IT)....
Lonza’s Acquisition of Synaffix
Grey Wolf Therapeutics’ $49 Million Series B Funding Round
In UK DLA Piper, Goodwin Procter, advised on the matter. DLA Piper advised Earlybird Venture Capital GmbH & Co. KG , Pfizer Ventures with a team...
AbbVie’s Acquisition of Syndesi
In UK Goodwin Procter, advised on the matter. Goodwin Procter advised Syndesi Therapeutics with a team including Andrew Harrow (Picture – Corporate M&A), Malcolm Bates (IP&IT)....
Exscientia’s $510.4 Million IPO
In UK Cooley LLP, Goodwin Procter, advised on the matter. Cooley LLP advised Exscientia with a team including David Boles (Picture – Equity Capital Markets), Claire...
Vaccitech’s $168 Million Series B Financing Round
In UK Goodwin Procter, advised on the matter. Goodwin Procter advised Vaccitech with a team including Duncan Greenhalgh (IP&IT). Vaccitech announced the completion of its $168 million...